标题
Pharmacogenetics of antipsychotics: recent progress and methodological issues
作者
关键词
-
出版物
Expert Opinion on Drug Metabolism & Toxicology
Volume 9, Issue 2, Pages 183-191
出版商
Informa Healthcare
发表日期
2012-12-01
DOI
10.1517/17425255.2013.736964
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effectiveness of a Cognitive Behavioral Weight Management Intervention in Obese Patients With Psychotic Disorders Compared to Patients With Nonpsychotic Disorders or No Psychiatric Disorders
- (2012) Jian-Ping Zhang et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Pharmacogenetics in psychiatry: translating research into clinical practice
- (2011) A K Malhotra et al. MOLECULAR PSYCHIATRY
- Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications
- (2011) T A P Lett et al. MOLECULAR PSYCHIATRY
- Metabolic syndrome with the atypical antipsychotics
- (2011) Pornpoj Pramyothin et al. Current Opinion in Endocrinology Diabetes and Obesity
- D2Receptor Genetic Variation and Clinical Response to Antipsychotic Drug Treatment: A Meta-Analysis
- (2010) Jian-Ping Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Personalized Medicine for Depression: Can We Match Patients With Treatments?
- (2010) Gregory E. Simon et al. AMERICAN JOURNAL OF PSYCHIATRY
- Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction
- (2010) Jian-Ping Zhang et al. Expert Opinion on Drug Metabolism & Toxicology
- Lack of association between the −759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients
- (2010) Y.-M. Park et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Candidate Gene Analysis Identifies a Polymorphism inHLA-DQB1Associated With Clozapine-Induced Agranulocytosis
- (2010) Maria C. Athanasiou et al. JOURNAL OF CLINICAL PSYCHIATRY
- Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
- (2010) D E Adkins et al. MOLECULAR PSYCHIATRY
- Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment
- (2010) Chen-Jee Hong et al. Pharmacogenetics and Genomics
- DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia
- (2010) Todd Lencz et al. Pharmacogenetics and Genomics
- Polymorphisms of theHTR2Cgene and antipsychotic-induced weight gain: an update and meta-analysis
- (2010) Michelle N Sicard et al. PHARMACOGENOMICS
- Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain
- (2010) D J Müller et al. PHARMACOGENOMICS JOURNAL
- Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden
- (2009) Frida Renström et al. HUMAN MOLECULAR GENETICS
- Applicability of a Genetic Signature for Enhanced Iloperidone Efficacy in the Treatment of Schizophrenia
- (2009) Simona Volpi et al. JOURNAL OF CLINICAL PSYCHIATRY
- Medication Adherence: A Review of the Literature and Implications for Clinical Practice
- (2009) Rose J. Julius et al. Journal of Psychiatric Practice
- Olanzapine-induced weight gain is associated with the −759C/T and −697G/C polymorphisms of the HTR2C gene
- (2009) B R Godlewska et al. PHARMACOGENOMICS JOURNAL
- G-protein β3 Subunit Gene 825C/T Polymorphism Is Not Associated with Olanzapine-Induced Weight Gain in Korean Schizophrenic Patients
- (2009) Young-Min Park et al. Psychiatry Investigation
- Association of antipsychotic induced weight gain and body mass index with GNB3 gene: A meta-analysis
- (2008) Renan P. Souza et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More